These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 31188423)

  • 1. Dengue Infection Complicated by Hemophagocytic Lymphohistiocytosis: Experiences From 180 Patients With Severe Dengue.
    Kan FK; Tan CC; Von Bahr Greenwood T; Khalid KE; Supramaniam P; Hed Myrberg I; Tan LH; Henter JI
    Clin Infect Dis; 2020 May; 70(11):2247-2255. PubMed ID: 31188423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe Dengue and Associated Hemophagocytic Lymphohistiocytosis in PICU.
    Bhattacharya D; Angurana SK; Nallasamy K; Iyer R; Jayashree M
    Indian J Pediatr; 2019 Dec; 86(12):1094-1098. PubMed ID: 31353429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for secondary hemophagocytic lymphohistiocytosis in severe coronavirus disease 2019 adult patients.
    Meng M; Chen L; Zhang S; Dong X; Li W; Li R; Deng Y; Wang T; Xu Y; Liu J; Huang Y; Chen Y; Huang S; Wen Z; Zhang L; Du H; Liu Y; Annane D; Qu J; Chen D
    BMC Infect Dis; 2021 Apr; 21(1):398. PubMed ID: 33926377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum soluble interleukin-2 receptor (sIL-2R) is an accurate biomarker for dengue-associated hemophagocytic lymphohistiocytosis syndrome diagnosed by Hscore.
    Mahabala C; Koushik VK; Manjrekar PA; Balanthimogru P
    Infection; 2023 Apr; 51(2):433-438. PubMed ID: 35999341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical features and risk factors for secondary hemophagocytic lymphohistiocytosis in elderly patients with severe SARS-CoV-2 infection: a multicenter retrospective cohort study].
    Deng Y; Lu S; Zhang G; Sun W; Chu Y; Meng M; Cui Y; Li P
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2023 Aug; 35(8):793-799. PubMed ID: 37593855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemophagocytic lymphohistiocytosis as a rare complication of dengue haemorrhagic fever: a case report.
    Pradeep C; Karunathilake P; Abeyagunawardena S; Ralapanawa U; Jayalath T
    J Med Case Rep; 2023 Jun; 17(1):224. PubMed ID: 37259116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dengue-associated hemophagocytic lymphohistiocytosis in an adult: A case report and literature review.
    Chung SM; Song JY; Kim W; Choi MJ; Jeon JH; Kang S; Jung E; Noh JY; Cheong HJ; Kim WJ
    Medicine (Baltimore); 2017 Feb; 96(8):e6159. PubMed ID: 28225498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and Laboratory Characteristics of Hemophagocytic Lymphohistiocytosis in Children With Severe Dengue During the 2019-2020 Outbreak in Southern Colombia.
    Restrepo Arias VC; Salgado García DM; Merchán-Galvis AM; Narváez CF
    Pediatr Infect Dis J; 2023 Jun; 42(6):e204-e211. PubMed ID: 36916863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and Risk Factors for Developing Dengue-Associated Hemophagocytic Lymphohistiocytosis in Puerto Rico, 2008 - 2013.
    Ellis EM; Sharp TM; Pérez-Padilla J; González L; Poole-Smith BK; Lebo E; Baker C; Delorey MJ; Torres-Velasquez B; Ochoa E; Rivera-Garcia B; Díaz-Pinto H; Clavell L; Puig-Ramos A; Janka GE; Tomashek KM
    PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004939. PubMed ID: 27556807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome analysis of pediatric hemophagocytic lymphohistiocytosis.
    Chen TY; Hsu MH; Kuo HC; Sheen JM; Cheng MC; Lin YJ
    J Formos Med Assoc; 2021 Jan; 120(1 Pt 1):172-179. PubMed ID: 32307323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe COVID-19-associated hyperinflammatory syndrome versus classic hemophagocytic lymphohistiocytosis: similarities, differences, and the way forward.
    Yadav G; Malhotra H; Mehta P; Sachu R; Rizvi I; Bharti VR; Kumar M; Kumar N; Ali W; Verma SP; Puri B; Dandu H
    J Investig Med; 2023 Mar; 71(3):244-253. PubMed ID: 36803041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe dengue due to secondary hemophagocytic lymphohistiocytosis: A case study.
    Ray U; Dutta S; Mondal S; Bandyopadhyay S
    IDCases; 2017; 8():50-53. PubMed ID: 28409119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemophagocytic lymphohistiocytosis syndrome in Dengue hemorrhagic fever.
    Raju S; Kalyanaraman S; Swaminathan K; Nisha A; Praisid S
    Indian J Pediatr; 2014 Dec; 81(12):1381-3. PubMed ID: 24728701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemophagocytic lymphohistiocytosis in critically ill patients: diagnostic reliability of HLH-2004 criteria and HScore.
    Knaak C; Nyvlt P; Schuster FS; Spies C; Heeren P; Schenk T; Balzer F; La Rosée P; Janka G; Brunkhorst FM; Keh D; Lachmann G
    Crit Care; 2020 May; 24(1):244. PubMed ID: 32448380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble Interleukin-2 Receptor Level as a Marker of Hemophagocytic Lymphohistiocytosis in Children With Severe Dengue.
    Singh D; Raghunathan V; Dhaliwal M; Rastogi N; Chadha R; Yadav SP
    Front Pediatr; 2021; 9():721857. PubMed ID: 34778128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Retrospective Review of Secondary Hemophagocytic Lymphohistiocytosis (HLH) and Dengue-associated HLH from a Teaching Hospital in Singapore.
    Tso ACY; Acharyya S; Fong SZ; Lee LK; Sreekanth SV; Fan BE; Chan SWS; Ong KH
    Clin Hematol Int; 2024; 6(1):116-127. PubMed ID: 38817699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and Outcome of Secondary Hemophagocytic Lymphohistiocytosis Among SIRS Patients: Results from a Prospective Cohort Study.
    Gualdoni GA; Hofmann GA; Wohlfarth P; Winkler HM; Winkler S; Haslacher H; Thalhammer R; Makristathis A; Ratzinger F; Burgmann H
    J Clin Med; 2019 Apr; 8(4):. PubMed ID: 31010216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Etoposide Therapy of Cytokine Storm Syndromes.
    Henter JI; von Bahr Greenwood T
    Adv Exp Med Biol; 2024; 1448():525-551. PubMed ID: 39117837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical analysis and follow-up study of Epstein-Barr virus associated-hemophagocytic lymphohistiocytosis in childhood].
    Lu G; Xie ZD; Shen KL; Wu RH; Jin YK; Yang S; Liu CY
    Zhonghua Er Ke Za Zhi; 2010 Feb; 48(2):121-6. PubMed ID: 20426937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin 1 Receptor Antagonist Anakinra, Intravenous Immunoglobulin, and Corticosteroids in the Management of Critically Ill Adult Patients With Hemophagocytic Lymphohistiocytosis.
    Wohlfarth P; Agis H; Gualdoni GA; Weber J; Staudinger T; Schellongowski P; Robak O
    J Intensive Care Med; 2019 Sep; 34(9):723-731. PubMed ID: 28631531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.